Postoperative Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Postoperative Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-06-15FDA Approved: ONDANSETRON — Original Application (JVET PHARMACEUTICALS LLC)
FDA approved a generic ondansetron product from JVET Pharmaceuticals LLC under the Original Application, authorizing its marketing.
-
CLINICAL_TRIALS trial_result · 2012-05-10Clinical Trial Update: Effect of Intravenous Fluid Therapy on Postoperative Vomiting in Children Undergoing Otorhinolaryngological Surgery [Phase 3]
This entry notes the completion of a Phase 3 clinical trial investigating whether intravenous fluid therapy reduces postoperative vomiting i…
-
FDA approval · 2012-04-30FDA Approved: ONDANSETRON — Supplemental Application (West-Ward Pharmaceuticals Corp)
FDA approved a supplemental application for ondansetron from West-Ward Pharmaceuticals Corp under ANDA076781. This action grants regulatory …
-
FDA approval · 2012-04-30FDA Approved: ONDANSETRON — Supplemental Application (West-Ward Pharmaceuticals Corp)
The FDA approved a supplemental application for ondansetron submitted by West-Ward Pharmaceuticals Corp under ANDA076780, authorizing change…
-
FDA approval · 2012-04-27FDA Approved: ONDANSETRON — Supplemental Application (AvPAK)
FDA approves a supplemental application for ondansetron from AvPAK under an ANDA. This action updates the labeling/approval status of this g…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-04-18FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
The FDA approved a supplemental application for granisetron hydrochloride from Mylan Institutional LLC, enabling its continued marketing as …
-
FDA approval · 2012-04-18FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for granisetron hydrochloride (generic) from Mylan Institutional LLC. This action updates the produc…
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition [Phase 1]
This update reports the completion of a Phase 1 bioequivalence study of Ondansetron 8 mg tablets under fasting conditions.
-
CLINICAL_TRIALS trial_result · 2012-03-30Clinical Trial Update: Aprepitant for Prevention of Postoperative Nausea and Vomiting in Elective Hysterectomy [Phase 4]
A Phase 4 trial evaluating aprepitant to prevent postoperative nausea and vomiting in women undergoing elective hysterectomy was terminated;…
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: Continuous Infusion of Palonosetron for Preventing of Postoperative Nausea and Vomiting [NA]
Clinical trial update on continuous infusion of palonosetron to prevent postoperative nausea and vomiting. The status of the trial is unknow…
-
FDA approval · 2012-03-14FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
The FDA approved a supplemental application for metoclopramide hydrochloride from Chartwell Governmental & Specialty RX, LLC., signaling an …
-
FDA approval · 2012-03-08FDA Approved: METOCLOPRAMIDE — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for metoclopramide from Ipca Laboratories Limited.
-
FDA approval · 2012-02-17FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for ondansetron hydrochloride from Hikma Pharmaceuticals USA Inc., resulting in the approval of a ge…
-
CLINICAL_TRIALS research · 2012-02-17Clinical Trial Update: Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer [Phase 2]
Phase 2 clinical trial update on Ramosetron, Aprepitant, and Dexamethasone (RAD) in solid tumors, including cancer indications and postopera…
-
CLINICAL_TRIALS trial_result · 2012-02-16Clinical Trial Update: Decreasing the Incidence of Post-Operative Nausea and Vomiting (PONV) in Bariatric Patients [NA]
Completed clinical trial evaluating methods to decrease postoperative nausea and vomiting in bariatric surgery patients.
-
FDA approval · 2012-02-13FDA Approved: ONDANSETRON — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's supplemental application for ondansetron hydrochloride (generic ondansetron) under ANDA 0761…
-
CLINICAL_TRIALS research · 2012-02-07Clinical Trial Update: Effect of Intravenous Patient-controlled Analgesia (IV-PCA) With Fentanyl in Adults for Acute Postoperative Pain Control
Clinical trial update evaluating intravenous patient-controlled analgesia with fentanyl for acute postoperative pain control in adults. The …
-
CLINICAL_TRIALS trial_result · 2012-02-03Clinical Trial Update: Efficacy of Dexamethasone Added to Ramosetron for Preventing Postoperative Nausea and Vomiting in Highly Susceptible Patients Following Spine Surgery [Phase 4]
Phase 4 clinical trial update evaluating whether adding dexamethasone to Ramosetron improves prevention of postoperative nausea and vomiting…
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: Trial of a Transversus Abdominis Plane (TAP) Block in Laparoscopic Colorectal Surgery [NA]
Trial assessing the use of a transversus abdominis plane (TAP) block in laparoscopic colorectal surgery to influence postoperative pain and …
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: Evaluation of 2 Doses of Intravenous Droperidol in the Prevention of Postoperative Nausea [Phase 4]
Phase 4 trial evaluating two intravenous doses of droperidol to prevent postoperative nausea and vomiting has been terminated.
-
FDA approval · 2011-12-07FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Natco Pharma Limited)
The FDA approved a supplemental application for granisetron hydrochloride from Natco Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery [Phase 4]
Phase 4 trial update evaluating aprepitant for prophylaxis of postoperative nausea and vomiting in outpatient plastic surgery; results compl…
-
CLINICAL_TRIALS trial_result · 2011-11-23Clinical Trial Update: Comparison of TIVA (Total Intravenous Anesthesia) and TIVA Plus Palonosetron in Preventing Postoperative Nausea and Vomiting [NA]
A completed clinical trial comparing total intravenous anesthesia (TIVA) alone versus TIVA with palonosetron to prevent postoperative nausea…
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: Palonosetron Versus Ramosetron for the Prevention of Postoperative Nausea and Vomiting [NA]
This clinical trial update notes the completion of a head-to-head trial comparing palonosetron and ramosetron for preventing postoperative n…
-
FDA approval · 2011-10-25FDA Approved: COMPRO — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for COMPRO (prochlorperazine) from Padagis US LLC. Prochlorperazine is an antiemetic used to treat n…